Quick Answer
TherapeuticsMD, Inc. reported Gross Profit of $1.30 million for fiscal year 2023.
TherapeuticsMD, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2023 | $1.30M | -98.1% |
| 2022 | $68.57M | +5755.3% |
| 2021 | $1.17M | -97.6% |
| 2020 | $48.90M | +12.9% |
| 2019 | $43.31M | +224.1% |
| 2018 | $13.36M | -5.5% |
| 2017 | $14.14M | -6.8% |
| 2016 | $15.17M | -3.0% |
| 2015 | $15.64M | +37.7% |
| 2014 | $11.35M | +66.6% |
| 2013 | $6.82M | +176.0% |
| 2012 | $2.47M | +116.5% |
| 2011 | $1.14M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | -$53.0K | — | -112.1% |
| June 30, 2023 | $437.0K | — | +5.0% |
| March 31, 2023 | $416.0K | -97.1% | — |
| September 30, 2022 | $0.00 | -100.0% | — |
| June 30, 2022 | $0.00 | -100.0% | -100.0% |
| March 31, 2022 | $14.47M | -4.7% | -28.1% |
| September 30, 2021 | $20.12M | +25.3% | +6.7% |
| June 30, 2021 | $18.87M | +199.5% | +24.3% |
- TherapeuticsMD, Inc. showed a decrease of -98.1% in Gross Profit compared to the prior fiscal year.
- Over the 2011–2023 period, TherapeuticsMD, Inc.’s gross profit has grown by 14.1% (from $1.14 million to $1.30 million).
- The most recent figure is from TherapeuticsMD, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 29, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: